Development of Spontaneous Autoimmune Peripheral Polyneuropathy in B7-2–Deficient Nod Mice

An increasing number of studies have documented the central role of T cell costimulation in autoimmunity. Here we show that the autoimmune diabetes-prone nonobese diabetic (NOD) mouse strain, deficient in B7-2 costimulation, is protected from diabetes but develops a spontaneous autoimmune peripheral polyneuropathy. All the female and one third of the male mice exhibited limb paralysis with histologic and electrophysiologic evidence of severe demyelination in the peripheral nerves beginning at 20 wk of age. No central nervous system lesions were apparent. The peripheral nerve tissue was infiltrated with dendritic cells, CD4+, and CD8+ T cells. Finally, CD4+ T cells isolated from affected animals induced the disease in NOD.SCID mice. Thus, the B7-2–deficient NOD mouse constitutes the first model of a spontaneous autoimmune disease of the peripheral nervous system, which has many similarities to the human disease, chronic inflammatory demyelinating polyneuropathy (CIDP). This model demonstrates that NOD mice have “cryptic” autoimmune defects that can polarize toward the nervous tissue after the selective disruption of CD28/B7-2 costimulatory pathway.

[1]  Colin McKerlie,et al.  Type I Diabetes and Multiple Sclerosis Patients Target Islet Plus Central Nervous System Autoantigens; Nonimmunized Nonobese Diabetic Mice Can Develop Autoimmune Encephalitis1 , 2001, The Journal of Immunology.

[2]  J. Bluestone,et al.  B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. , 2000, Immunity.

[3]  J. Bluestone,et al.  A Critical Role for B7/CD28 Costimulation in Experimental Autoimmune Encephalomyelitis: A Comparative Study Using Costimulatory Molecule-Deficient Mice and Monoclonal Antibody Blockade1 , 2000, The Journal of Immunology.

[4]  M. M. Griffiths,et al.  Mapping autoimmunity genes. , 1999, Current opinion in immunology.

[5]  V. Kuchroo,et al.  Studies in B7-Deficient Mice Reveal a Critical Role for B7 Costimulation in Both Induction and Effector Phases of Experimental Autoimmune Encephalomyelitis , 1999, The Journal of experimental medicine.

[6]  K. Becker,et al.  Comparative genetics of type 1 diabetes and autoimmune disease: common loci, common pathways? , 1999, Diabetes.

[7]  J. Seidman,et al.  QTL influencing autoimmune diabetes and encephalomyelitis map to a 0.15-cM region containing Il2 , 1999, Nature Genetics.

[8]  J. Todd,et al.  From genome to aetiology in a multifactorial disease, type 1 diabetes , 1999, BioEssays : news and reviews in molecular, cellular and developmental biology.

[9]  T. Mak,et al.  CD28-deficient mice are highly resistant to collagen-induced arthritis. , 1999, Journal of immunology.

[10]  H. Mcdevitt,et al.  The role of MHC class II molecules in susceptibility and resistance to autoimmunity. , 1998, Current opinion in immunology.

[11]  H. Hartung,et al.  Guillain-Barré syndrome, CIDP and other chronic immune-mediated neuropathies. , 1998, Current opinion in neurology.

[12]  J. Trent,et al.  Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Nitin J. Karandikar,et al.  Tissue-specific up-regulation of B7-1 expression and function during the course of murine relapsing experimental autoimmune encephalomyelitis. , 1998, Journal of immunology.

[14]  Nitin J. Karandikar,et al.  Treatment with intact anti-B7-1 mAb during disease remission enhances epitope spreading and exacerbates relapses in R-EAE , 1997, Journal of Neuroimmunology.

[15]  E. Simpson,et al.  B7-1 and B7-2 have overlapping, critical roles in immunoglobulin class switching and germinal center formation. , 1997, Immunity.

[16]  E. Fuchs,et al.  CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. , 1996, Immunity.

[17]  N. Maclaren,et al.  Although DR3-DQB1*0201 may be associated with multiple component diseases of the autoimmune polyglandular syndromes, the human leukocyte antigen DR4-DQB1*0302 haplotype is implicated only in beta-cell autoimmunity. , 1996, The Journal of clinical endocrinology and metabolism.

[18]  Nitin J. Karandikar,et al.  Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. , 1995, Immunity.

[19]  Laurie H Glimcher,et al.  B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy , 1995, Cell.

[20]  J. Bluestone,et al.  Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse , 1995, The Journal of experimental medicine.

[21]  A. Cooke,et al.  Mycobacteria precipitate an SLE-like syndrome in diabetes-prone NOD mice. , 1994, Immunology.

[22]  P. Linsley,et al.  Treatment of murine lupus with CTLA4Ig. , 1994, Science.

[23]  J. Allison,et al.  CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones , 1992, Nature.

[24]  P. Pozzilli,et al.  Parathyroiditis in the non-obese diabetic mouse--a new finding. , 1991, The Journal of endocrinology.

[25]  P. Linsley,et al.  Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation , 1991, The Journal of experimental medicine.

[26]  R. Schwartz,et al.  Antigen presentation by chemically modified splenocytes induces antigen- specific T cell unresponsiveness in vitro and in vivo , 1987, The Journal of experimental medicine.

[27]  S. Hsu,et al.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[28]  J. Bluestone,et al.  Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. , 2001, Annual review of immunology.